chr10-101023921-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001195263.2(PDZD7):​c.367+7A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.593 in 1,614,028 control chromosomes in the GnomAD database, including 287,387 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.63 ( 31608 hom., cov: 33)
Exomes 𝑓: 0.59 ( 255779 hom. )

Consequence

PDZD7
NM_001195263.2 splice_region, intron

Scores

3
Splicing: ADA: 0.00002722
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.591

Publications

13 publications found
Variant links:
Genes affected
PDZD7 (HGNC:26257): (PDZ domain containing 7) This gene encodes a ciliary protein homologous to proteins which are mutated in Usher syndrome patients, and mutations and translocations involving this gene have been associated with two types of Usher syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2010]
PDZD7 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive 57
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • Usher syndrome type 2C
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 10-101023921-T-C is Benign according to our data. Variant chr10-101023921-T-C is described in ClinVar as Benign. ClinVar VariationId is 46211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.789 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDZD7NM_001195263.2 linkc.367+7A>G splice_region_variant, intron_variant Intron 3 of 16 ENST00000619208.6 NP_001182192.1 Q9H5P4-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDZD7ENST00000619208.6 linkc.367+7A>G splice_region_variant, intron_variant Intron 3 of 16 5 NM_001195263.2 ENSP00000480489.1 Q9H5P4-3

Frequencies

GnomAD3 genomes
AF:
0.635
AC:
96500
AN:
152082
Hom.:
31573
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.796
Gnomad AMI
AF:
0.615
Gnomad AMR
AF:
0.570
Gnomad ASJ
AF:
0.549
Gnomad EAS
AF:
0.404
Gnomad SAS
AF:
0.523
Gnomad FIN
AF:
0.505
Gnomad MID
AF:
0.725
Gnomad NFE
AF:
0.602
Gnomad OTH
AF:
0.613
GnomAD2 exomes
AF:
0.565
AC:
142062
AN:
251388
AF XY:
0.564
show subpopulations
Gnomad AFR exome
AF:
0.800
Gnomad AMR exome
AF:
0.477
Gnomad ASJ exome
AF:
0.558
Gnomad EAS exome
AF:
0.402
Gnomad FIN exome
AF:
0.517
Gnomad NFE exome
AF:
0.604
Gnomad OTH exome
AF:
0.589
GnomAD4 exome
AF:
0.589
AC:
860722
AN:
1461828
Hom.:
255779
Cov.:
65
AF XY:
0.587
AC XY:
426665
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.804
AC:
26931
AN:
33480
American (AMR)
AF:
0.491
AC:
21963
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.560
AC:
14626
AN:
26136
East Asian (EAS)
AF:
0.417
AC:
16538
AN:
39700
South Asian (SAS)
AF:
0.528
AC:
45556
AN:
86258
European-Finnish (FIN)
AF:
0.521
AC:
27801
AN:
53390
Middle Eastern (MID)
AF:
0.663
AC:
3822
AN:
5768
European-Non Finnish (NFE)
AF:
0.601
AC:
667755
AN:
1111976
Other (OTH)
AF:
0.592
AC:
35730
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
22187
44374
66562
88749
110936
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18098
36196
54294
72392
90490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.635
AC:
96575
AN:
152200
Hom.:
31608
Cov.:
33
AF XY:
0.626
AC XY:
46552
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.796
AC:
33062
AN:
41546
American (AMR)
AF:
0.569
AC:
8697
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.549
AC:
1903
AN:
3468
East Asian (EAS)
AF:
0.404
AC:
2093
AN:
5178
South Asian (SAS)
AF:
0.522
AC:
2515
AN:
4820
European-Finnish (FIN)
AF:
0.505
AC:
5348
AN:
10590
Middle Eastern (MID)
AF:
0.728
AC:
214
AN:
294
European-Non Finnish (NFE)
AF:
0.601
AC:
40893
AN:
67986
Other (OTH)
AF:
0.610
AC:
1289
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1764
3528
5292
7056
8820
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
776
1552
2328
3104
3880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.611
Hom.:
26952
Bravo
AF:
0.648
Asia WGS
AF:
0.486
AC:
1693
AN:
3478
EpiCase
AF:
0.610
EpiControl
AF:
0.612

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

367+7A>G in Intron 03 of PDZD7: This variant is not expected to have clinical si gnificance because it is not located within the conserved splice consensus seque nce and has been identified in 40.2% (2823/7020) of European American chromosome s from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.w ashington.edu/EVS; dbSNP rs6584410). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 2C Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hearing loss, autosomal recessive 57 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.29
DANN
Benign
0.39
PhyloP100
-0.59
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000027
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6584410; hg19: chr10-102783678; COSMIC: COSV64645720; API